Benzocaine for Koi Fish: Sedation, Euthanasia Context & Safety

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Benzocaine is an immersion anesthetic that may be used by aquatic veterinarians to sedate or anesthetize koi for short procedures, transport-related handling, diagnostics, or humane end-of-life care. In fish medicine, it is placed in water at a measured concentration so the medication passes across the gills. It is not a routine home remedy, and it should not be used without your vet's direction.

In the United States, tricaine methanesulfonate (MS-222) is the only FDA-approved fish anesthetic, while benzocaine products are used in more limited or investigational contexts. The U.S. Fish & Wildlife Service lists BENZOAK VET, a 20% benzocaine immersion product, for anesthetic and sedative use in finfish under its INAD program, with treatment concentrations of 10-150 mg/L for up to 15 minutes. That does not make every benzocaine product interchangeable, and human oral benzocaine products are not appropriate substitutes for koi care.

Benzocaine also appears in euthanasia guidance for fish. Merck Veterinary Manual, adapted from the AVMA euthanasia guidelines, lists buffered benzocaine or benzocaine hydrochloride as acceptable fish immersion agents in the euthanasia setting. In practice, your vet may still prefer other agents depending on the koi's size, water temperature, intended procedure, and whether the fish is ornamental or part of a food-producing population.

In koi, benzocaine is mainly used for short-term sedation or anesthesia when a fish needs to be handled with less struggling and stress. That may include skin scraping, gill biopsy, wound care, imaging, transport preparation, scale or fin procedures, or other brief hands-on treatments. Sedation can improve safety for the fish and for the veterinary team when used correctly.

It may also be used as part of a humane euthanasia protocol directed by your vet. Fish euthanasia often uses a two-step approach: first an anesthetic overdose to produce unconsciousness, then a secondary method to ensure death. This matters because fish can have persistent cardiac activity after loss of consciousness, so visual stillness alone is not enough.

Benzocaine is not an antibiotic, pain medication, or water conditioner. It does not treat ulcers, parasites, buoyancy problems, or poor water quality. If your koi is isolating, refusing food, rolling, gasping, or showing skin lesions, the priority is a veterinary exam and water-quality review rather than trying to sedate the fish at home.

Benzocaine dosing in fish is highly species-, temperature-, and goal-dependent. Published fish guidance for BENZOAK VET lists 10-150 mg/L as an immersion bath for up to 15 minutes, with the exact concentration adjusted to the desired depth of sedation and the fish's response. Lower concentrations are used for lighter sedation, while deeper anesthesia requires higher concentrations and closer monitoring. Your vet may also adjust the plan based on pond water chemistry, dissolved oxygen, and the koi's size and health status.

Benzocaine is poorly soluble in water, so formulations and preparation matter. Some protocols use benzocaine hydrochloride or dissolve benzocaine in alcohol before dilution. That is one reason home mixing is risky. An inaccurate concentration can lead to inadequate sedation, prolonged recovery, respiratory arrest, or death.

For euthanasia, dosing is intentionally much higher than procedural sedation and should only be performed by your vet or trained personnel following accepted fish euthanasia guidance. Do not estimate doses by body weight alone, and do not reuse bath water between fish. If a koi is intended for human consumption, withdrawal rules also matter: the U.S. Fish & Wildlife Service lists a 72-hour investigational withdrawal period for doses up to 100 mg/L and 96 hours for 101-150 mg/L with BENZOAK VET, and euthanized fish must not enter the food chain.

The main risks with benzocaine in koi are respiratory depression, loss of equilibrium, prolonged recovery, and overdose. A koi under anesthesia may first become less reactive, then lose normal posture and opercular rhythm as anesthesia deepens. If the fish becomes motionless too quickly, has very slow gill movement, or fails to recover promptly in clean, oxygenated water, that is an emergency.

Water conditions strongly affect safety. Warm water, low oxygen, crowding, and poor water quality can all reduce the margin of safety. Sick koi, fish with gill disease, and fish already weakened by parasites, ulcers, or severe systemic illness may tolerate anesthetics poorly.

Because benzocaine products and solvents vary, irritation or toxicity can also come from the formulation rather than the active ingredient alone. Your vet may choose a different anesthetic if recovery quality is a concern or if the koi has significant gill compromise. After any anesthetic event, the fish should be monitored for normal upright swimming, steady gill movement, and return of normal social behavior and appetite.

Formal fish-specific interaction studies for benzocaine are limited, so your vet will usually think in terms of additive physiologic effects rather than a long list of proven interactions. The biggest concern is combining benzocaine with other sedatives, anesthetics, or stressful procedures that further suppress breathing and gill ventilation. That can deepen anesthesia faster than expected.

Your vet will also consider recent exposure to other immersion products, including tricaine, eugenol-based anesthetics, disinfectants, or water treatments. If more than one regulated aquatic drug is used, withdrawal periods may change. The U.S. Fish & Wildlife Service notes that when BENZOAK VET is used with another authorized INAD drug, the longest withdrawal time should be followed.

Tell your vet about everything that has gone into the pond or hospital tank, including salt, formalin, potassium permanganate, parasite treatments, antibiotics, and any over-the-counter fish products. Even when a direct chemical interaction is not proven, the combined stress of poor water quality, active disease, and sedation can change how safely a koi handles benzocaine.